| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.110 | 46.064 | 37.032 | 9.992 | 12.409 | 9.602 | 7.974 | 10.998 | 11.061 | 6.773 |
| Total Income - EUR | 47.115 | 46.083 | 74.607 | 10.331 | 12.414 | 9.606 | 7.977 | 11.000 | 11.062 | 6.774 |
| Total Expenses - EUR | 36.544 | 40.061 | 35.085 | 4.645 | 8.131 | 7.819 | 6.825 | 7.300 | 8.768 | 4.189 |
| Gross Profit/Loss - EUR | 10.571 | 6.022 | 39.522 | 5.686 | 4.282 | 1.787 | 1.151 | 3.700 | 2.294 | 2.586 |
| Net Profit/Loss - EUR | 9.157 | 5.561 | 38.776 | 5.586 | 4.159 | 1.690 | 1.072 | 3.591 | 2.183 | 2.150 |
| Employees | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medvest Comexim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 970 | 791 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 30.137 | 23.172 | 55.200 | 10.619 | 10.211 | 11.737 | 7.634 | 5.640 | 7.857 | 6.799 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.374 | 269 | 319 | 687 | 135 | 521 | 130 | 130 | 130 | 7 |
| Cash | 27.762 | 22.903 | 54.881 | 9.932 | 10.075 | 11.216 | 7.504 | 5.509 | 7.727 | 6.792 |
| Shareholders Funds | 9.256 | 5.744 | 44.421 | 8.903 | 9.518 | 11.029 | 6.880 | 4.832 | 7.001 | 6.340 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 21.851 | 18.219 | 10.778 | 1.715 | 692 | 708 | 754 | 808 | 856 | 459 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6110 - 6110" | |||||||||
| CAEN Financial Year |
6110
|
|||||||||
Comments - Medvest Comexim Srl